Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 336

1.

The effect of a three-tier formulary on antidepressant utilization and expenditures.

Hodgkin D, Parks Thomas C, Simoni-Wastila L, Ritter GA, Lee S.

J Ment Health Policy Econ. 2008 Jun;11(2):67-77.

PMID:
18509214
2.

Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.

Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Muriel AC, Frank RG.

Arch Gen Psychiatry. 2005 Apr;62(4):435-41.

3.

Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance.

Klepser DG, Huether JR, Handke LJ, Williams CE.

J Manag Care Pharm. 2007 Nov-Dec;13(9):765-77.

4.

The effect of three-tier formulary adoption on medication continuation and spending among elderly retirees.

Huskamp HA, Deverka PA, Landrum MB, Epstein RS, McGuigan KA.

Health Serv Res. 2007 Oct;42(5):1926-42.

5.

Employer drug benefit plans and spending on prescription drugs.

Joyce GF, Escarce JJ, Solomon MD, Goldman DP.

JAMA. 2002 Oct 9;288(14):1733-9. Erratum in: JAMA 2002 Nov 20;288(19):2409.

PMID:
12365957
6.

The effect of incentive-based formularies on prescription-drug utilization and spending.

Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Frank RG.

N Engl J Med. 2003 Dec 4;349(23):2224-32.

7.
8.

Management of Newer Antidepressant Medications in U.S. Commercial Health Plans.

Hodgkin D, Horgan CM, Creedon TB, Merrick EL, Stewart MT.

J Ment Health Policy Econ. 2015 Dec;18(4):165-73.

9.
10.

Effect of a three-tier prescription copay on pharmaceutical and other medical utilization.

Motheral B, Fairman KA.

Med Care. 2001 Dec;39(12):1293-304.

PMID:
11717571
11.

The relationship of antidepressant prescribing concentration to treatment duration and cost.

Hodgkin D, Merrick EL, Hiatt D.

J Ment Health Policy Econ. 2012 Mar;15(1):3-11.

12.
13.
14.
15.

Formulary management in the Department of Defense.

Trice S, Devine J, Mistry H, Moore E, Linton A.

J Manag Care Pharm. 2009 Mar;15(2):133-46.

16.

Management of access to branded psychotropic medications in private health plans.

Hodgkin D, Horgan CM, Garnick DW, Len Merrick E, Volpe-Vartanian J.

Clin Ther. 2007 Feb;29(2):371-80.

PMID:
17472830
17.
18.

Incentive formularies and changes in prescription drug spending.

Landon BE, Rosenthal MB, Normand SL, Spettell C, Lessler A, Underwood HR, Newhouse JP.

Am J Manag Care. 2007 Jun;13(6 Pt 2):360-9.

19.

Are incentive-based formularies inversely associated with drug utilization in managed care?

Gleason PP, Gunderson BW, Gericke KR.

Ann Pharmacother. 2005 Feb;39(2):339-45. Epub 2005 Jan 11. Review.

PMID:
15644478
20.

Supplemental Content

Support Center